Akums Drugs & Pharmaceuticals Ltd Share Price
(AKUMS)
₹455.5
as on 04:01PM, 28 Feb 2025
Akums Drugs & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹445.05Day's Price Range₹475.1552 Week's Low
52 Week's High
₹445.0552-Week Price Range₹1,175.9
| Returns % | |
| 1 Month Return | -20.45 % |
| 3 Month Return | -26.38 % |
| 1 Year Return | -42.79 % |
| Market Stats | |
| Previous Close | ₹473.40 |
| Open | ₹470.80 |
| Volume | 11.46L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹7,169.30Cr |
Akums Drugs & Pharmaceuticals Ltd Key Statistics
P/E Ratio
45.78
PEG Ratio
5.96
Market Cap
₹7,169.30 Cr
P/B Ratio
0EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
91.28
Akums Drugs & Pharmaceuticals Ltd Mutual Fund Holdings
Akums Drugs & Pharmaceuticals Ltd Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Akums Drugs & Pharmaceuticals Ltd. An average target of ₹775
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Share analysis
Akums Drugs & Pharmaceuticals Ltd price forecast by 2 analysts
Upside of70.14%
High
₹840
Target
₹775.00
Low
₹710
Akums Drugs & Pharmaceuticals Ltd target price ₹775, a slight upside of 70.14% compared to current price of ₹455.5. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Akums Drugs & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Akums Drugs & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Akums Drugs & Pharmaceuticals Ltd
Akums Drugs Receives Positive Outlook from ICICI Securities - 10 Feb, 2025
ICICI Securities upgraded Akums Drugs to 'BUY' with a target price of Rs 710, citing recovery in CDMO business, improved EBITDA margins, and a significant contract in Europe.Akums Drugs Reports Growth Amid European Expansion - 08 Feb, 2025
Akums Drugs and Pharmaceuticals Ltd. reported a 12% YoY increase in Adjusted EBITDA for Q4 2024, driven by improved profitability in its CDMO segment. Despite a 6.1% decline in total income, the company is expanding globally with a €200 million contract for the European market, emphasizing its commitment to innovation and strategic growth.Akums Drugs Faces Profit Decline Amid Revenue Drop - 07 Feb, 2025
Akums Drugs & Pharmaceuticals reported a significant decline in net profit and revenue for Q3, with a 66% drop in profit. Despite this, adjusted profit rose 15%. The company is also expanding its operations with new subsidiaries in Europe.I-T Department Searches Akums Offices and Executives - 24 Jan, 2025
The Income Tax Department conducted searches at Akums Drugs & Pharmaceuticals' offices and the residences of its managing directors and CFO from January 15 to 21. The company has not received any communication regarding the search outcome.Akums Drugs Stock Falls After IT Search - 22 Jan, 2025
Akums Drugs and Pharmaceuticals Ltd's stock fell 7% following an Income Tax Department search at its offices. The company assured full cooperation and minimal disruption to operations.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 5.18% to 5.54% in Dec 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 7.15% to 8.65% in Dec 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 6 months, AKUMS stock has moved down by -45.4%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.34% to 6.36% in Dec 2024 quarter
Akums Drugs & Pharmaceuticals Ltd Financials
Index Inclusions
Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 75.26% | 0.00 | |
| Foreign Institutions | 6.36% | ||
| Mutual Funds | 5.54% | 7.08 | |
| Retail Investors | 8.65% | 21.03 | |
| Others | 4.18% |
Akums Drugs & Pharmaceuticals Ltd Key Indicators
Akums Drugs & Pharmaceuticals Ltd Valuation
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (29.26x)
November 18, 2024
Today (45.78x)
February 28, 2025
Industry (50.30x)
February 28, 2025
Highest (66.86x)
August 19, 2024
Akums Drugs & Pharmaceuticals Ltd Earnings and Dividends
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit fell -66.35% since last year same period to ₹65.18Cr in the Q3 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -0.05% fall in its net profits since last 3-months.
Read More about Earnings Results
Akums Drugs & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Akums Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Akums Drugs & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹7,169.30 Cr | -8.56% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
| BUY | ₹11,541.60 Cr | -6.3% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| NA | ₹150.63 Cr | 55.12% | 0.51 | NA | NA | |
| NA | ₹49.04 Cr | 9.71% | 0.68 | NA | NA | |
| NA | ₹171.17 Cr | 81.39% | 0.58 | NA | NA |
About Akums Drugs & Pharmaceuticals Ltd
Share Price: ₹455.50 per share as on 28 Feb, 2025 04:01 PM
Market Capitalisation: ₹7,169.30Cr as of today
Revenue: ₹1,010.41Cr as on December 2024 (Q4 24)
Net Profit: ₹66.31Cr as on December 2024 (Q4 24)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Akums Drugs & Pharmaceuticals Ltd
What is Akums Drugs & Pharmaceuticals Ltd price today?
Akums Drugs & Pharmaceuticals Ltd share price today stands at ₹455.5, Open: ₹470.8, Previous Close: ₹473.4, High: ₹475.15, Low: ₹445.05, 52 Week High: ₹1175.9, 52 Week Low: ₹445.05.
How to Buy Akums Drugs & Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Akums Drugs & Pharmaceuticals Ltd shares
Is Akums Drugs & Pharmaceuticals Ltd listed on NSE?
Akums Drugs & Pharmaceuticals Ltd is listed on NSE
Is Akums Drugs & Pharmaceuticals Ltd listed on BSE?
Akums Drugs & Pharmaceuticals Ltd is listed on BSE
What are today's High and Low prices of Akums Drugs & Pharmaceuticals Ltd?
- Today's highest price of Akums Drugs & Pharmaceuticals Ltd is ₹475.15.
- Today's lowest price of Akums Drugs & Pharmaceuticals Ltd is ₹445.05.
What are today's traded volumes of Akums Drugs & Pharmaceuticals Ltd?
Today's traded volume of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is 11.46L.
What is today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd?
Today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is ₹7169.3Cr.
What is the 52 Week High and Low Range of Akums Drugs & Pharmaceuticals Ltd?
How much percentage Akums Drugs & Pharmaceuticals Ltd is down from its 52 Week High?
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price is ₹455.5. It is down -61.26% from its 52 Week High price of ₹1175.9
How much percentage Akums Drugs & Pharmaceuticals Ltd is up from its 52 Week low?
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price is ₹455.5. It is up 2.35% from its 52 Week Low price of ₹445.05
What are the historical returns of Akums Drugs & Pharmaceuticals Ltd?
What is the PE ratio of Akums Drugs & Pharmaceuticals Ltd today?
PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 45.78
PE ratio = Akums Drugs & Pharmaceuticals Ltd Market price per share / Akums Drugs & Pharmaceuticals Ltd Earnings per share